Enliven Therapeutics, Inc (ELVN) Misses Q1 EPS by 7c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q1 EPS of ($0.57), $0.07 worse than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Popular stocks with increasing option volume: MU PLTR DELL INTC SPCX PCG AVGO SOFI MSTR NFLX IREN ORCL
• Compass Diversified (CODI) 7500 contracts of December 13 calls trade